Atrophic enteropathy refractory to a gluten-free diet: what should we consider?

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Olmesartan is an angiotensin II receptor antagonist used for the treatment of blood hypertension. Long-term use has been associated with diarrhea and sometimes intestinal involvement may mimic enteropathies such as celiac disease. Clinicians should consider drugs within the differential diagnosis of enteropathies. We report the case of a female who sought medical help for malabsorptive symptoms and was finally diagnosed with olmesartan-associated gastritis and atrophic enteropathy.

Cite

CITATION STYLE

APA

Martín-Lagos Maldonado, A., García-Consuegra Ruiz-Aragón, F., & Herrera Mercader, M. D. C. (2020). Atrophic enteropathy refractory to a gluten-free diet: what should we consider? Revista Espanola de Enfermedades Digestivas : Organo Oficial de La Sociedad Espanola de Patologia Digestiva, 112(4), 328–329. https://doi.org/10.17235/reed.2020.6361/2019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free